MMP Inhibition in Prostate Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (57)
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 • 2,774 citations
Cancer statistics, 1998
1998 • 2,407 citations
Biology and biochemistry of proteinases in tumor invasion
1993 • 1,264 citations
The Endocrinology and Developmental Biology of the Prostate*
1987 • 1,047 citations
Carcinoma of the Prostate
1991 • 755 citations
Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs
1991 • 522 citations
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.
1991 • 449 citations
Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
1986 • 412 citations
Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and Marimastat
1997 • 403 citations
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
1993 • 383 citations
THE RÔLE OF THE VERTEBRAL VEINS IN METASTATIC PROCESSES
1942 • 317 citations
Metastatic Model for Human Prostate Cancer Using Orthotopic Implantation in Nude Mice
1992 • 310 citations
Spread of prostatic cancer to bone
1983 • 289 citations
Steps in tumor metastasis: new concepts from intravital videomicroscopy
1995 • 268 citations
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
1993 • 201 citations
Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic Mice
1995 • 190 citations
Prostate and Bone Fibroblasts Induce Human Prostate Cancer Growth in Vivo: Implications for Bidirectional Tumor-Stromal Cell Interaction in Prostate Carcinoma Growth and Metastasis
1992 • 188 citations
Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue.
1993 • 181 citations
In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer.
1997 • 156 citations
Host modulation with tetracyclines and their chemically modified analogues.
1992 • 148 citations
Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.
1998 • 139 citations
Suppression of Invasion by Inducible Expression of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in B 16-F10 Melanoma Cells
1992 • 137 citations
Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression.
1996 • 135 citations
Involvement of Urokinase and its Receptor in the Invasiveness of Human Prostatic Carcinoma Cell Lines
1991 • 132 citations
Proteases and Protease Inhibitors in Tumor Progression
1997 • 124 citations
Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
1993 • 119 citations
Matrix metalloproteinase inhibitors 1998
1998 • 115 citations
Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases.
1992 • 93 citations
Orthotopic implantation of human prostate cancer cell lines: A clinically relevant animal model for metastatic prostate cancer
1997 • 87 citations
Origin and biology of cancer metastasis
1989 • 86 citations
Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer
1997 • 85 citations
Effects of doxycycline on human prostate cancer cells in vitro
1998 • 82 citations
Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis.
1986 • 75 citations
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer
1997 • 75 citations
Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice.
1996 • 74 citations
Androgen Deprivation as a Strategy for Prostate Cancer Chemoprevention
1997 • 73 citations
The mitochondrial genetic system as a target for chemotherapy: Tetracyclines as cytostatics
1984 • 63 citations
Diversity of Melanoma Plasma Membrane Proteinases: Inhibition of Collagenolytic and Cytolytic Activities by Minocycline<xref ref-type="fn" rid="FN2">2</xref>
1985 • 59 citations
Patterns of metastasis by the human prostate cancer cell line PC‐3 in athymic nude mice
1989 • 51 citations
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells
1996 • 51 citations
Matrilysin Expression in the Involuting Rat Ventral Prostate
1996 • 49 citations
Inhibition of Tumor Angiogenesisa
1994 • 45 citations
IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression.
1997 • 45 citations
Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy.
1995 • 43 citations
Prostatic tumor (R3327) skeletal metastasis
1990 • 41 citations
Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer
1993 • 34 citations
Clinical Trials of a Low Molecular Weight Matrix Metalloproteinase Inhibitor in Cancer
1994 • 33 citations
Potential Application of a Chemically Modified Non-Antimicrobial Tetracycline (CMT-3) Against Metastatic Prostate Cancer
1998 • 30 citations
Acid-activated insulin-like growth factor binding protein protease activity of Cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma
1997 • 29 citations
Medical approaches in the management of prostatic disease
1997 • 26 citations
The Management of Hormone Refractory Prostate Cancer
1996 • 26 citations
HPLC determination of a chemically modified nonantimicrobial tetracycline: Biological implications
1992 • 25 citations
RECENT ADVANCES IN THE MEDICAL MANAGEMENT OF PROSTATE CANCER
1996 • 24 citations
Endocrine Therapy for Prostate Cancer: Recent Developments and Current Status
1993 • 19 citations
Analysis of the TIMP‐1/FIB‐CL Complexa
1994 • 9 citations
Current treatment of advanced prostate cancer.
1997 • 9 citations
Mini review: Proteases and invasion in human prostate epithelial cell lines: Implications in prostate cancer prevention and intervention
1995 • 7 citations